Updating results

228 results

Sort: Relevance | Date

Renin-angiotensin system drugs: dual therapy (KTT2)

The key therapeutic topic renin-angiotensin system drugs: dual therapy has been retired from the 2017 update of medicines optimisation: key therapeutic topics. The version published in 2016 is available here for information but it has not been updated since February 2016. Like all the other key therapeutic topics it is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated February 2016

Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide (KTT24)

This document summarises the evidence base on suicide prevention: optimising medicines and reducing access to medicines as a means of suicide. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published March 2019 Last updated September 2019

Shared decision making (KTT23)

This document summarises the evidence base on shared decision making. It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance.

Key therapeutic topic Published March 2019 Last updated September 2019

Antimicrobial stewardship: prescribing antibiotics (KTT9)

This document summarises the evidence base on antimicrobial stewardship: prescribing antibiotics. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated September 2019

Antipsychotics in people living with dementia (KTT7)

This document summarises the evidence base on antipsychotics in people living with dementia. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated September 2019

Hypnotics (KTT6)

This document summarises the evidence base on hypnotics. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated September 2019

Asthma: medicines safety priorities (KTT5)

This document summarises the evidence base on asthma: medicines safety priorities. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated September 2019

Lipid-modifying drugs (KTT3)

This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on lipid-modifying drugs. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated September 2019

Chemotherapy dose standardisation (KTT22)

This document summarises the evidence base on chemotherapy dose standardisation. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published February 2018 Last updated September 2019

Medicines optimisation in chronic pain (KTT21)

This document summarises the evidence base on medicines optimisation in chronic pain. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2017 Last updated September 2019

First-choice antidepressant use in adults with depression or generalised anxiety disorder (KTT8)

The key therapeutic topic first-choice antidepressant use in adults with depression or generalised anxiety disorder has been retired from the 2017 update of medicines optimisation: key therapeutic topics. The version published in 2016 is available here for information but it has not been updated since February 2016. Like all the other key therapeutic topics it is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated February 2016

Laxatives (KTT1)

The key therapeutic topic laxatives has been retired from the 2016 update of medicines optimisation: key therapeutic topics. The version published in 2015 is available here for information but it has not been updated since January 2015. Like all the other key therapeutic topics it is not formal NICE guidance.

Key therapeutic topic Published January 2015

Minocycline (KTT11)

The key therapeutic topic minocycline has been retired from the 2016 update of medicines optimisation: key therapeutic topics. The version published in 2015 is available here for information but it has not been updated since January 2015. Like all the other key therapeutic topics it is not formal NICE guidance.

Key therapeutic topic Published January 2015

Safer insulin prescribing (KTT20)

This document summarises the evidence base on safer insulin prescribing. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2017 Last updated September 2019

Psychotropic medicines in people with learning disabilities whose behaviour challenges (KTT19)

This document summarises the evidence base on psychotropic medicines in people with learning disabilities whose behaviour challenges. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2017 Last updated September 2019

Multimorbidity and polypharmacy (KTT18)

This document summarises the evidence base on multimorbidity and polypharmacy. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2017 Last updated September 2019

Acute kidney injury (AKI): use of medicines in people with or at increased risk of AKI (KTT17)

This document summarises the evidence base on the use of medicines in people with or at increased risk of acute kidney injury. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published February 2016 Last updated September 2019

Anticoagulants, including direct-acting oral anticoagulants (DOACs) (KTT16)

This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on anticoagulants, including direct-acting oral anticoagulants (DOACs). It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published February 2016 Last updated September 2019

Biosimilar medicines (KTT15)

The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance.

Key therapeutic topic Published February 2016 Last updated February 2018

Wound care products (KTT14)

This document summarises the evidence base on wound care products. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated September 2019

Non-steroidal anti-inflammatory drugs (KTT13)

The key therapeutic topic non-steroidal anti-inflammatory drugs has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated February 2018

Type 2 diabetes mellitus: medicines optimisation priorities (KTT12)

This document summarises the evidence base on type 2 diabetes mellitus: medicines optimisation priorities. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated September 2019

Plus Sutures for preventing surgical site infection (MIB204)

NICE has developed a medtech innovation briefing (MIB) on Plus Sutures for preventing surgical site infection

Medtech innovation briefing Published February 2020

Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children (MIB163)

Advice on the use of Serve-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children to aid local decision-making

Medtech innovation briefing Published October 2018

The Oncentra Prostate v4.x for ultrasound‑guided real‑time HDR brachytherapy in men with localised prostate cancer (MIB16)

Advice on the use of Oncentra Prostate v4.x for ultrasound-guided real-time HDR brachytherapy in men with localised prostate cancer to aid local decision-making

Medtech innovation briefing Published December 2014

The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs (MIB159)

Advice on the use of The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs to aid local decision-making

Medtech innovation briefing Published September 2018

Rezum for treating benign prostatic hyperplasia (MIB158)

Advice on the use of Rezum (NxThera Inc) for treating benign prostatic hyperplasia (BPH) to aid local decision-making

Medtech innovation briefing Published August 2018

AlignRT in breast cancer radiotherapy (MIB157)

Advice on the use of AlignRT (Vision RT) in breast cancer radiotherapy to aid local decision-making

Medtech innovation briefing Published August 2018

Neon EEG electrode for EEG monitoring in newborns (MIB155)

Advice on the use of Neon electroencephalogram (EEG) electrode for EEG monitoring in newborns to aid local decision-making

Medtech innovation briefing Published August 2018

Mechanical thrombectomy devices for acute ischaemic stroke (MIB153)

Advice on the use of mechanical thrombectomy devices for acute ischaemic stroke

Medtech innovation briefing Published July 2018

Remote ECG interpretation consultancy services for cardiovascular disease (MIB152)

Advice on the use of remote electrocardiogram (ECG) interpretation consultancy services for cardiovascular disease to aid local decision-making

Medtech innovation briefing Published July 2018

Airglove air warming system for venous access (MIB151)

Advice on the use of Airglove air warming system for venous access to aid local decision-making

Medtech innovation briefing Published July 2018

ORA G3 to measure corneal hysteresis (MIB150)

Advice on the use of ORA (Ocular Response Analyzer) G3 for measuring corneal hysteresis during diagnosis and management of glaucoma to aid local decision-making

Medtech innovation briefing Published June 2018

Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions (MIB15)

Advice on the use of Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions to aid local decision-making

Medtech innovation briefing Published December 2014

PredictSure-IBD for inflammatory bowel disease prognosis (MIB178)

Advice on PredictSure-IBD for inflammatory bowel disease prognosis to aid local decision making

Medtech innovation briefing Published March 2019

Kendall DL for ECG monitoring in people having cardiac surgery (MIB177)

Advice on Kendall DL for ECG monitoring in people having cardiac surgery to aid local decision making

Medtech innovation briefing Published March 2019

IQoro for hiatus hernia (MIB176)

Advice on the use of IQoro for hiatus hernia to aid local decision making

Medtech innovation briefing Published March 2019

IQoro for stroke-related dysphagia (MIB175)

Advice on the use of IQoro for stroke-related dysphagia to aid local decision making

Medtech innovation briefing Published March 2019

CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery disease (MIB174)

Advice on the use of CADScor system for ruling out coronary artery disease in people with stable coronary artery disease symptoms to aid local decision-making

Medtech innovation briefing Published March 2019

Prevena incision management system for closed surgical incisions (MIB173)

Advice on the use of Prevena incision management system for closed surgical incisions to aid local decision making

Medtech innovation briefing Published February 2019

Axumin for functional imaging of prostate cancer recurrence (MIB172)

Advice on the use of Axumin for functional imaging of prostate cancer recurrence to aid local decision making

Medtech innovation briefing Published February 2019

StoneChecker for kidney stone evaluation (MIB171)

Advice on the use of StoneChecker for kidney stone evaluation to aid local decision making

Medtech innovation briefing Published February 2019

Path Finder for freezing of gait in people with Parkinson's disease (MIB170)

Advice on the use of Path Finder for freezing of gait in people with Parkinson’s disease to aid local decision-making

Medtech innovation briefing Published January 2019

The Space GlucoseControl system for managing blood‑glucose in critically ill patients in intensive care (MIB17)

Advice on the use of the Space GlucoseControl system for managing blood-glucose in critically ill patients in intensive care to aid local decision-making

Medtech innovation briefing Published December 2014

RT300 for spinal cord injury rehabilitation (MIB169)

Advice on the use of RT300 for spinal cord injury rehabilitation to aid local decision making

Medtech innovation briefing Published January 2019

LiMAx system for assessing the functional capacity of the liver (MIB168)

Advice on the use of LiMAx system for assessing the functional capacity of the liver to aid local decision making

Medtech innovation briefing Published January 2019

Video laryngoscopes to help intubation in people with difficult airways (MIB167)

Advice on the use of video laryngoscopy to help intubation in people with difficult airways to aid local decision-making

Medtech innovation briefing Published December 2018

Galaxy UNYCO for temporary stabilisation of lower limb fractures (MIB166)

Advice on the use of Galaxy UNYCO (single-use, external fixation system) for temporary stabilisation of lower limb fractures to aid local decision-making

Medtech innovation briefing Published December 2018

Cerebrotech Visor for detecting stroke (MIB165)

Advice on the use of Cerebrotech Visor for detecting stroke to aid local decision-making

Medtech innovation briefing Published December 2018

Axonics sacral neuromodulation system for overactive bladder and faecal incontinence (MIB164)

Advice on the use of Axonics sacral neuromodulation system (SNM) for overactive bladder and faecal incontinence to aid local decision-making

Medtech innovation briefing Published December 2018